Uric acid and cardiovascular disease

G Ndrepepa - Clinica chimica acta, 2018 - Elsevier
Uric acid (UA) is an end product of purine metabolism in humans and great apes. UA acts as
an antioxidant and it accounts for 50% of the total antioxidant capacity of biological fluids in …

[HTML][HTML] Novel biomarkers for cardiovascular risk prediction

J Wang, GJ Tan, LN Han, YY Bai, M He… - Journal of geriatric …, 2017 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The
primary prevention of CVD is dependent upon the ability to identify high-risk individuals long …

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

MA Becker, HR Schumacher, LR Espinoza… - Arthritis research & …, 2010 - Springer
Introduction The purpose of this study was to compare urate-lowering (UL) efficacy and
safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA)≥ 8.0 …

[PDF][PDF] Is it time to revise the normal range of serum uric acid levels?

G Desideri, G Castaldo, A Lombardi… - European Review for …, 2014 - europeanreview.org
The actual reference range of serum uric acid has been assessed according to its variations
among healthy individuals. ie those without clinical evidence of gout. By this approach …

Uric acid and evolution

B Álvarez-Lario, J Macarrón-Vicente - Rheumatology, 2010 - academic.oup.com
Uric acid (UA) is the end product of purine metabolism in humans due to the loss of uricase
activity by various mutations of its gene during the Miocene epoch, which led to humans …

Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies

G Zhao, L Huang, M Song, Y Song - Atherosclerosis, 2013 - Elsevier
Objective Serum uric acid (SUA) levels have been used to predict cardiovascular and all-
cause mortality event, but the data have yielded conflicting results. We investigated whether …

Hyperuricemia, cardiovascular disease, and hypertension

M Kuwabara - Pulse, 2016 - karger.com
In recent years, there has been an increase in the prevalence of hyperuricemia, and the
latter has attracted attention as an adult lifestyle-associated disease, together with …

[HTML][HTML] Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme

MG Battelli, A Bolognesi, L Polito - … Acta (BBA)-Molecular Basis of Disease, 2014 - Elsevier
The enzyme xanthine oxidoreductase (XOR) catalyses the last step of purine degradation in
the highest uricotelic primates as a rate-limiting enzyme in nucleic acid catabolism. Although …

Serum uric acid level as an independent risk factor for all‐cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study

JH Chen, SY Chuang, HJ Chen… - Arthritis Care & …, 2009 - Wiley Online Library
Objective The association between hyperuricemia and cardiovascular events has been
documented in high‐risk groups, but is still undetermined in general populations, especially …

Relation of serum uric acid to cardiovascular disease

AH Wu, JD Gladden, M Ahmed, A Ahmed… - International journal of …, 2016 - Elsevier
This review summarizes recent published literature on the association between serum uric
acid and cardiovascular disease, a relationship which is complex and not fully elucidated …